| Application number | Title of the application | Filing Date | Status |
|---|
| 08/418914 | PROCESS FOR THE PREPARATION OF WATER SOLUBLE CAMPTOTHECIN ANALOGS AND INTERMEDIATES THEREOF, COMPOUNDS PREPARED BY SAID PROCESS, AND METHODS OF USE THEREBY | Apr 6, 1995 | Abandoned |
Array
(
[id] => 3631270
[patent_doc_number] => 05686617
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Methods for the preparation of Benzotriazole herbicidal agents'
[patent_app_type] => 1
[patent_app_number] => 8/417343
[patent_app_country] => US
[patent_app_date] => 1995-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8465
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686617.pdf
[firstpage_image] =>[orig_patent_app_number] => 417343
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/417343 | Methods for the preparation of Benzotriazole herbicidal agents | Apr 4, 1995 | Issued |
Array
(
[id] => 3815669
[patent_doc_number] => 05710275
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => '7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/341602
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47970
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/710/05710275.pdf
[firstpage_image] =>[orig_patent_app_number] => 341602
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/341602 | 7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors | Apr 2, 1995 | Issued |
Array
(
[id] => 3731085
[patent_doc_number] => 05652365
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Process for the production of finasteride'
[patent_app_type] => 1
[patent_app_number] => 8/411685
[patent_app_country] => US
[patent_app_date] => 1995-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3774
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652365.pdf
[firstpage_image] =>[orig_patent_app_number] => 411685
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/411685 | Process for the production of finasteride | Mar 29, 1995 | Issued |
Array
(
[id] => 3622599
[patent_doc_number] => 05593996
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Triazolopyrimidine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/412401
[patent_app_country] => US
[patent_app_date] => 1995-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16613
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593996.pdf
[firstpage_image] =>[orig_patent_app_number] => 412401
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/412401 | Triazolopyrimidine derivatives | Mar 27, 1995 | Issued |
Array
(
[id] => 3659821
[patent_doc_number] => 05659036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate'
[patent_app_type] => 1
[patent_app_number] => 8/409931
[patent_app_country] => US
[patent_app_date] => 1995-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11314
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 391
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/659/05659036.pdf
[firstpage_image] =>[orig_patent_app_number] => 409931
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/409931 | Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | Mar 22, 1995 | Issued |
Array
(
[id] => 3530714
[patent_doc_number] => 05583138
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => '17.beta.-substituted 4-azaandrostane derivatives, pharmaceutical compositions containing them and process for preparing same'
[patent_app_type] => 1
[patent_app_number] => 8/406920
[patent_app_country] => US
[patent_app_date] => 1995-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8582
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583138.pdf
[firstpage_image] =>[orig_patent_app_number] => 406920
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/406920 | 17.beta.-substituted 4-azaandrostane derivatives, pharmaceutical compositions containing them and process for preparing same | Mar 22, 1995 | Issued |
Array
(
[id] => 3733817
[patent_doc_number] => 05693810
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => '17 .beta.-carboxanilides of 4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/406898
[patent_app_country] => US
[patent_app_date] => 1995-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5327
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693810.pdf
[firstpage_image] =>[orig_patent_app_number] => 406898
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/406898 | 17 .beta.-carboxanilides of 4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors | Mar 20, 1995 | Issued |
Array
(
[id] => 3648662
[patent_doc_number] => 05639741
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => '17-amino substituted 4-azasteroid 5.alpha.-reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/338472
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12205
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 759
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639741.pdf
[firstpage_image] =>[orig_patent_app_number] => 338472
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338472 | 17-amino substituted 4-azasteroid 5.alpha.-reductase inhibitors | Mar 19, 1995 | Issued |
| 08/403759 | BRAIN CELL PROTECTIVE AGENT | Mar 16, 1995 | Abandoned |
Array
(
[id] => 3626048
[patent_doc_number] => 05620986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => '17 urea, thiourea, thiocarbamyl and carbamyl4-azasteroid 5-reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders'
[patent_app_type] => 1
[patent_app_number] => 8/338574
[patent_app_country] => US
[patent_app_date] => 1995-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9885
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 902
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620986.pdf
[firstpage_image] =>[orig_patent_app_number] => 338574
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338574 | 17 urea, thiourea, thiocarbamyl and carbamyl4-azasteroid 5-reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders | Feb 28, 1995 | Issued |
Array
(
[id] => 3518474
[patent_doc_number] => 05506228
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-09
[patent_title] => '2,6-diaryl pyridazinones with immunosuppressant activity'
[patent_app_type] => 1
[patent_app_number] => 8/392580
[patent_app_country] => US
[patent_app_date] => 1995-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/506/05506228.pdf
[firstpage_image] =>[orig_patent_app_number] => 392580
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392580 | 2,6-diaryl pyridazinones with immunosuppressant activity | Feb 22, 1995 | Issued |
Array
(
[id] => 3728435
[patent_doc_number] => 05670504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-23
[patent_title] => '2,6-diaryl pyridazinones with immunosuppressant activity'
[patent_app_type] => 1
[patent_app_number] => 8/392588
[patent_app_country] => US
[patent_app_date] => 1995-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26352
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 405
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/670/05670504.pdf
[firstpage_image] =>[orig_patent_app_number] => 392588
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392588 | 2,6-diaryl pyridazinones with immunosuppressant activity | Feb 22, 1995 | Issued |
Array
(
[id] => 3590011
[patent_doc_number] => 05585382
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Polycyclic and heterocyclic chromophores for bis-imide tumoricidals'
[patent_app_type] => 1
[patent_app_number] => 8/392018
[patent_app_country] => US
[patent_app_date] => 1995-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28808
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 559
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585382.pdf
[firstpage_image] =>[orig_patent_app_number] => 392018
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392018 | Polycyclic and heterocyclic chromophores for bis-imide tumoricidals | Feb 20, 1995 | Issued |
Array
(
[id] => 3430255
[patent_doc_number] => 05463070
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-31
[patent_title] => 'Hypoglycemic hydroxyurea derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/391308
[patent_app_country] => US
[patent_app_date] => 1995-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9828
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/463/05463070.pdf
[firstpage_image] =>[orig_patent_app_number] => 391308
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/391308 | Hypoglycemic hydroxyurea derivatives | Feb 16, 1995 | Issued |
Array
(
[id] => 3590653
[patent_doc_number] => 05567707
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-22
[patent_title] => 'Acronycine analogues'
[patent_app_type] => 1
[patent_app_number] => 8/389798
[patent_app_country] => US
[patent_app_date] => 1995-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/567/05567707.pdf
[firstpage_image] =>[orig_patent_app_number] => 389798
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/389798 | Acronycine analogues | Feb 15, 1995 | Issued |
Array
(
[id] => 3623693
[patent_doc_number] => 05602141
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Camptothecin derivatives and process for their preparation'
[patent_app_type] => 1
[patent_app_number] => 8/389190
[patent_app_country] => US
[patent_app_date] => 1995-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6395
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602141.pdf
[firstpage_image] =>[orig_patent_app_number] => 389190
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/389190 | Camptothecin derivatives and process for their preparation | Feb 14, 1995 | Issued |
Array
(
[id] => 3590513
[patent_doc_number] => 05516904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-14
[patent_title] => 'Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity'
[patent_app_type] => 1
[patent_app_number] => 8/384886
[patent_app_country] => US
[patent_app_date] => 1995-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10569
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/516/05516904.pdf
[firstpage_image] =>[orig_patent_app_number] => 384886
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/384886 | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity | Feb 6, 1995 | Issued |
Array
(
[id] => 3613629
[patent_doc_number] => 05534516
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1, 2, 3, 4-tetrahydroquinolinyl group having retinoid-like activity'
[patent_app_type] => 1
[patent_app_number] => 8/385000
[patent_app_country] => US
[patent_app_date] => 1995-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13242
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/534/05534516.pdf
[firstpage_image] =>[orig_patent_app_number] => 385000
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/385000 | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1, 2, 3, 4-tetrahydroquinolinyl group having retinoid-like activity | Feb 6, 1995 | Issued |
| 08/382740 | ANTIVIRAL COMPOUNDS AND ANTIHYPERTENSIVE COMPOUNDS | Feb 1, 1995 | Abandoned |